PharmaMar

PharmaMar is a pharmaceutical company based in Madrid, Spain. It uses marine resources to develop drugs for cancer and Alzheimer's treatments. It is also involved in molecular testing, including COVID-19 testing, and genetic analysis. Its subsidiary, Sylentis, develops therapies that use RNA interference. The company is listed on the Madrid Stock Exchange and is part of the IBEX 35. It was founded in 1986.

 References 

Category:1986 establishments in Europe
Category:1980s establishments in Spain
Category:Manufacturing companies of Spain
Category:Pharmaceutical companies of Europe